Starling Oncology, Inc. Proceeds from Sale and Maturity of Marketable Securities
Starling Oncology, Inc. (STLN) reported Proceeds from Sale and Maturity of Marketable Securities of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2026-03-12
- Starling Oncology, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2025-12-31 was $0.00.
- Starling Oncology, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Starling Oncology, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Starling Oncology, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Starling Oncology, Inc. proceeds from sale and maturity of marketable securities for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Starling Oncology, Inc. proceeds from sale and maturity of marketable securities for fiscal 2024 was $50.00M, a 38.47% decline from fiscal 2023.
- Starling Oncology, Inc. proceeds from sale and maturity of marketable securities for fiscal 2023 was $81.26M.
- Starling Oncology, Inc. proceeds from sale and maturity of marketable securities for fiscal 2022 was $0.00.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $0.00 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $0.00 10-Q · filed 2025-08-13 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $10.00M derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $10.00M derived: sum of 3 quarters · filed 2026-03-12 | $30.00M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $10.00M derived: sum of 2 quarters · filed 2026-03-12 | $30.00M derived: sum of 3 quarters · filed 2026-03-12 | $50.00M 10-K · filed 2026-03-12 |
| 2024-09-30 | $10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $30.00M derived: sum of 2 quarters · filed 2025-11-13 | $50.00M 10-Q · filed 2025-11-13 | $62.56M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $20.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $40.00M 10-Q · filed 2025-08-13 | $52.56M derived: sum of 3 quarters · filed 2025-08-13 | $61.13M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $20.00M 10-Q · filed 2025-05-14 | $32.55M derived: sum of 2 quarters · filed 2025-05-14 | $41.13M derived: sum of 3 quarters · filed 2025-05-14 | $71.26M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $12.56M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $21.13M derived: sum of 2 quarters · filed 2025-03-26 | $51.26M derived: sum of 3 quarters · filed 2025-03-26 | $81.26M 10-K · filed 2025-03-26 |
| 2023-09-30 | $8.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $38.70M derived: sum of 2 quarters · filed 2024-11-13 | $68.70M 10-Q · filed 2024-11-13 | $68.70M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $30.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $60.13M 10-Q · filed 2024-08-13 | $60.13M derived: sum of 3 quarters · filed 2024-08-13 | $60.13M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $30.00M 10-Q · filed 2024-05-14 | $30.00M derived: sum of 2 quarters · filed 2024-05-14 | $30.00M derived: sum of 3 quarters · filed 2024-05-14 | $30.00M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-10 |